Monitoring left ventricular dilation in mice with PET

Journal of Nuclear Medicine

Volumn 46, Issue 9, 2005, Pages 1516-1521

  Stegger, Lars ^a   Schäfers, Klaus P ^a   Flögel, Ulrich ^b   Livieratos, Lefteris ^c   Hermann, Sven ^a   Jacoby, Christoph ^b   Keul, Petra ^d   Conway, Edward M ^e   Schober, Otmar ^a   Schrader, Jürgen ^b   Levkau, Bodo ^d   Schäfers, Michael ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Heart failure; Mice; PET; Segmentation

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; GLUCOSE METABOLISM; HEART LEFT VENTRICLE; HEART VENTRICLE VOLUME; INTERMETHOD COMPARISON; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AGING; ALGORITHM; ANIMAL; COMPUTER ASSISTED DIAGNOSIS; CONGESTIVE CARDIOMYOPATHY; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; METABOLISM; METHODOLOGY; SCINTISCANNING; THREE DIMENSIONAL IMAGING;

AGING; ALGORITHMS; ANIMALS; CARDIOMYOPATHY, DILATED; FLUORODEOXYGLUCOSE F18; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 27744486711     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Schelbert HR, Phelps ME, Hoffman EJ, Huang SC, Selin CE, Kuhl DE. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol. 1979;43:209-218.
2. Araujo LI, Lammertsma AA, Rhodes CG, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 1991;83:875-885.
3. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 1995;36:78-85.
4. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Position tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.
5. 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation. 1986;74:81-88.
6. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 1983;67:766-778.
7. 11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography. Eur J Nucl Med. 2000;27:7-17.
8. Schafers M, Dutka D, Rhodes CG, et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res. 1998;82:57-62.
9. Boyd HL, Gunn RN, Marinho NVS. Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography. Eur J Nucl Med. 1996;23:1594-1602.
10. Rajappan K, Livieratos L, Camici PG, Pennell DJ. Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med. 2002;43:806-810.
11. Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS. Position emission tomography imaging of cardiac reporter gene expression in living rats. Circulation. 2002;106:180-183.
12. Inubushi M, Jordan MC, Roos KP, et al. Nitrogen-13 ammonia cardiac positron emission tomography in mice: effects of clonidine-induced changes in cardiac work on myocardial perfusion. Eur J Nucl Med Mol Imaging. 2004;31:110-116.
13. Croteau E, Benard E, Cadorette J, et al. Quantitative gated PET for the assessment of left ventricular function in small animals. J Nucl Med. 2003;44:1655-1661.
14. Jeavons AP, Chandler RA, Dettmar CAR. A 3D HIDAC-PET camera with submillimetre resolution for imaging small animals. IEEE Trans Nucl Sci. 1999;46:468-473.
15. Reader AJ, Ally S, Bakatselos F, et al. One-pass list-mode EM algorithm for high resolution 3D PET image reconstruction into large arrays. IEEE Trans Nucl Sci. 2002;49:693-699.
16. Schafers KP, Reader AJ, Kriens M, Knoess C, Schober O, Schäfers M. Performance evaluation of the 32-module quadHIDAC small-animal PET scanner. J Nucl Med. 2005;46:996-1004.
17. Biedenstein S, Schafers M, Stegger L, Kuwert T, Schober O. Three-dimensional contour detection of left ventricular myocardium using elastic surfaces. Eur J Nucl Med. 1999;26:201-207.
18. Stegger L, Biedenstein S, Schafers KP, Schober O, Schafers MA. Elastic surface contour detection for the measurement of ejection fraction in myocardial perfusion SPET. Eur J Nucl Med. 2001;28:48-55.
19. Deveraux QL, Reed JC. IAP family proteins: suppressors of apoptosis. Genes Dev. 1999;13:239-252.
20. Zheng X, Conway EM, Kang C, Chen E, Wilson C, Winoto A. Essential role of survivin, a member of inhibitor of apoptosis proteins in T cell development, maturation and homeostasis. J Exp Med. 2004;199:69-80.
21. Missimer J, Madi Z, Honer M, et al. Performance evaluation of the 16-module quad-HIDAC small animal PET camera. Phys Med Biol. 2004;49:2069-2081.
22. Godecke A, Molojavyi A, Heger J, et al. Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. J Biol Chem. 2003;24:21761-21766.
23. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37:7-11.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
25. Levkau B, Hermann S, Theilmeier G, et al. High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation. 2004;110:3355-3359.